Black Rock Inc. Veracyte, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,211,371 shares of VCYT stock, worth $150 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,211,371

Previous 7,161,866 0.69%

Holding current value

$150 Million

Previous $197 Million 18.89%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$21.0 - $29.1 $1.04 Million - $1.44 Million	49,505 Added 0.69%	7,211,371 $160 Million
Q4 2023 Feb 13, 2024	BUY	$19.72 - $28.68 $5.37 Million - $7.81 Million	272,376 Added 3.95%	7,161,866 $197 Million
Q3 2023 Nov 13, 2023	BUY	$22.33 - $29.92 $244,915 - $328,162	10,968 Added 0.16%	6,889,490 $154 Million
Q2 2023 Aug 11, 2023	BUY	$20.96 - $26.99 $5.73 Million - $7.38 Million	273,342 Added 4.14%	6,878,522 $175 Million
Q1 2023 May 12, 2023	BUY	$20.58 - $27.89 $1.45 Million - $1.97 Million	70,611 Added 1.08%	6,605,180 $147 Million

Q4 2022 Feb 13, 2023	BUY	$15.31 - $29.94 $5.81 Million - $11.4 Million	379,225 Added 6.16%	6,534,569 $155 Million
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $1.61 Million - $2.71 Million	-96,996 Reduced 1.55%	6,155,344 $102 Million
Q2 2022 Aug 12, 2022	BUY	$15.45 - $29.52 $1.35 Million - $2.57 Million	87,222 Added 1.41%	6,252,340 $124 Million
Q1 2022 May 12, 2022	SELL	$21.94 - $42.51 $2.38 Million - $4.61 Million	-108,435 Reduced 1.73%	6,165,118 $170 Million
Q4 2021 Feb 10, 2022	SELL	$36.09 - $53.79 $4.76 Million - $7.09 Million	-131,856 Reduced 2.06%	6,273,553 $258 Million
Q3 2021 Nov 09, 2021	BUY	$35.62 - $52.97 $1.22 Million - $1.82 Million	34,347 Added 0.54%	6,405,409 $298 Million
Q2 2021 Aug 11, 2021	BUY	$32.94 - $56.62 $210 Million - $361 Million	6,371,062 New	6,371,062 $255 Million

Others Institutions Holding VCYT

# of Institutions

257

Shares Held

81.7M

Call Options Held

43K

Put Options Held

82K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.49B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account